BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

BIOA BioAge Labs Inc.

未开盘 12-18 16:00:00 EST

4.30

+0.20

+4.88%

盘后4.34

+0.04+0.93%

19:53 EST

最高5.12	最低3.97	成交量471.49万
今开4.80	昨收4.10	日振幅28.05%
总市值1.54亿	流通市值1.04亿	总股本3,585万
成交额2,102万	换手率19.45%	流通股本2,424万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":4.3,"timestamp":1734555600000,"preClose":4.1,"halted":0,"volume":4714861,"hourTrading":{"tag":"盘后","latestPrice":4.34,"preClose":4.3,"latestTime":"19:53 EST","volume":49315,"amount":213281.2229,"timestamp":1734569582727},"delay":0,"floatShares":24243246,"shares":35848738,"eps":-33.128242,"marketStatus":"未开盘","marketStatusCode":0,"change":0.2,"latestTime":"12-18 16:00:00 EST","open":4.8,"high":5.12,"low":3.97,"amount":21024844.812275402,"amplitude":0.280488,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-33.128242,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734598800000},"adr":0,"listingDate":1727323200000,"adjPreClose":4.1,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":4.83,"preClose":4.1,"latestTime":"09:29 EST","volume":565402,"amount":2683808.656553,"timestamp":1734532198507},"postHourTrading":{"tag":"盘后","latestPrice":4.34,"preClose":4.3,"latestTime":"19:53 EST","volume":49315,"amount":213281.2229,"timestamp":1734569582727},"volumeRatio":5.425081},"requestUrl":"/m/hq/s/BIOA/tweets","defaultTab":"tweets","newsList":[{"id":"2492518003","title":"BUZZ--美国股票走势-美国电池技术公司、奥利廉价直销店、BioAge 实验室","url":"https://stock-news.laohu8.com/highlight/detail?id=2492518003","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492518003?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:49","pubTimestamp":1734536958,"startTime":"0","endTime":"0","summary":"标普500指数  上涨0.17%，报6,060.78点；纳斯达克综合指数  上涨0.15%，报20,139.86点。** Cognition Therapeutics   : BUZZ - 因痴呆症药物在中期试验中达到主要目标而上涨   ** 通用磨坊  : BUZZ - 因下调年度利润预期而下跌   ** Oklo   : BUZZ - 因与人工智能公司斯维奇达成部署12吉瓦核电的协议而上涨   ** 捷普  : BUZZ - 因第一季度业绩超预期而上涨   ** Inotiv   : BUZZ - 因股票发行定价而下跌   ** Xometry   : BUZZ - 摩根大通将 Xometry 的评级提升至 \"增持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPL","COMM","SH","BIRK",".DJI","2NVD.UK","NVDS","XMTR","ESmain","BIOA","NVDX","NVDS.UK","GPCR","MU","ACHR","MTCH","DJX","VKTX","OEX",".IXIC","ANGI","JBL","DDM",".SPX","NVD2.UK","DXD","SNVD.UK","SSO","SDS","NVDA","IVV","NVIW.SI","SPXU","MYPS","NVD","GIS","SDOW","DOG","GETY","NOTV","OLLI","SPY","ABAT","PKG","UPRO","NVDU","YY","3NVD.UK","CGTX"],"gpt_icon":1},{"id":"2492577187","title":"BUZZ-BioAge Labs 因与诺华合作开发老年病药物而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2492577187","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492577187?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:19","pubTimestamp":1734535180,"startTime":"0","endTime":"0","summary":"12月18日 -  ** 药物开发商 BioAge Labs 的 BIOA.O 股价上涨 ~10% 至 4.52 美元 ** BIOA表示，它正在与瑞士制药商诺华NOVN.S合作 ，寻找治疗老年相关疾病的新药靶点。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241218:nL4T3NJ14I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2490774859","title":"BUZZ--美国股票走势-华纳兄弟、Seres Therapeutics、Enterprise Bancorp","url":"https://stock-news.laohu8.com/highlight/detail?id=2490774859","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490774859?lang=zh_cn&edition=full","pubTime":"2024-12-09 23:51","pubTimestamp":1733759515,"startTime":"0","endTime":"0","summary":".N美国东部时间10:30，道琼斯工业平均指数.DJI下跌0.04%，报44,626.17点；标普500指数.SPX下跌0.28%，报6,072.92点；纳斯达克综合指数.IXIC下跌0.33%，报19,794.60点。** Interpublic Group of Companies Inc IPG.N，上涨 11.0. ** Albemarle Corp ALB.N，上涨 6.7 标普500指数.PL.INX跌幅前三位的是 ** Vistra Corp VST.N，下跌 7.0. ** OneConnect Financial Technology Co Ltd OCFT.N，上涨 17.4 纽约证券交易所.PL.N百分比跌幅前三名： ** Redwire Corp RDW.N，下跌 10.5. nL6N3NA0ET  ** Riot Platforms Inc RIOT.O:BUZZ - 在宣布发行可转换债券以购买更多比特币后下跌。nL6N3NA0FG  ** Alexandria Real Estate Equities Inc ARE.N:BUZZ - 在批准 5 亿美元股票回购计划后上涨。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nL4T3NA17S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSY","RIO.UK","XIN","NVDY","SG","NVDX","IPG","NEM","DDOG","DOUG","PTVE","ACLX","VST","VSCO","INDB","RAD.AU","CHRW","SCCO","DOW","RDW","EBTC","M","RVNC","OCFT","TWI","ZEO","NVDS","CHTR","06638","ALB","FCX","WBD","NVDA","AEO","CMCSA","BIOA","ANGO","MCRB","BHP.AU","RIO.AU","NKLA","LDTC","ARE"],"gpt_icon":1},{"id":"2490778369","title":"BUZZ--美国股票走势-特斯拉、Nvidia、帕兰提尔","url":"https://stock-news.laohu8.com/highlight/detail?id=2490778369","media":"路透中文","labels":["event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490778369?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:12","pubTimestamp":1733753555,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nL4S3NA10T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RIOT","SG9999015358.SGD","CHRW","RDDT","NVD3.UK","2NVD.UK","BHP.AU","LU0654597011.USD","M","FCX","NVD2.UK","NVDD","NVDY","TSLA","ARE","LU2242650005.HKD","LU1130305938.SGD","NVDS.UK","LU0256863902.USD","IE00B894F039.SGD","NVD","NVDU","SCCO","LU0345770993.USD","NVDA","LU1430597077.USD","DOW","PLTR","3NVD.UK","RIO.AU","LU0831103253.SGD","LU2456880835.USD","BK4550","LU0320765059.SGD","VSCO","NVDS","ACLX","DDOG","NEM","LU0787776722.HKD","SNVD.UK","LU1868837300.USD","RIO.UK","AEO","ANGO","BIOA","NVDX","BK4549"],"gpt_icon":1},{"id":"2490260587","title":"BUZZ--美国股票走势-红迪网、道指、梅西百货","url":"https://stock-news.laohu8.com/highlight/detail?id=2490260587","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490260587?lang=zh_cn&edition=full","pubTime":"2024-12-09 20:21","pubTimestamp":1733746900,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      12月9日 - 周一美国股指期货表现低迷，此前标普500指数和纳斯达克指数因乐观的企业业绩预期而在上一交易日创下收盘纪录新高，同时投资者在等待本周晚些时候将公布的一份重要通胀报告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0300736062.USD","BK4529","BK4547","LU1223082196.USD","LU2272731782.SGD","BK4220","LU1223083913.SGD","LU1280957306.USD","BIOA","BK4579","BK4550","LU0345780281.USD","LU2462611646.USD","LU0055631609.USD","NEM","DDM","BK4554","IE00B19Z3B42.SGD","IE0002270589.USD",".DJI","UDOW","DJX","BK4535","LU0345781412.USD","LU0368265764.SGD","LU0456854461.SGD","BK4094","LU0278409577.USD","BK4534","LU0321505439.SGD","IE00BZ9MQY76.HKD","LU0724618789.USD","IE00B19Z9Z06.USD","LU0029864427.USD","BK4077","LU0612318385.USD","M","LU0788109121.HKD","SDOW","FCX","RDDT","VSCO","LU0330918003.SGD","LU1223082519.USD","ANGO","DOG","DOW","SCCO","DXD"],"gpt_icon":1},{"id":"2490747934","title":"BUZZ-肥胖症药物试验被叫停后，杰富瑞下调 BioAge 的预期收益率","url":"https://stock-news.laohu8.com/highlight/detail?id=2490747934","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490747934?lang=zh_cn&edition=full","pubTime":"2024-12-09 18:51","pubTimestamp":1733741485,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    12月9日 - ** 药物开发商 BioAge Labs    股价盘前下跌 ~70% 至 6.13 美元** 券商Jefferies将其股票评级从 \"买入 \"下调至 \"持有\"；将PT从42美元下调至7美元** 与上周五收盘价 20.09 美元相比，新 PT 值下跌了 65.2** 由于肝脏安全问题，该公司停止了中期肥胖症药物试验 (link)，因此券商下调了该公司的目标价。** 券商预计 \"股价将大幅下跌\"** 券商还将该公司的药物管线价值从 3 亿美元下调至 2 亿美元。** 截至上次收盘，该公司股价已累计下跌 10.7","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2490479377","title":"BUZZ-肥胖症药物试验被叫停后，杰富瑞下调 BioAge 的预期收益率","url":"https://stock-news.laohu8.com/highlight/detail?id=2490479377","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490479377?lang=zh_cn&edition=full","pubTime":"2024-12-09 18:51","pubTimestamp":1733741485,"startTime":"0","endTime":"0","summary":"** 券商预计 \"股价将大幅下跌\" ** 券商还将该公司的药物管线价值从 3 亿美元下调至 2 亿美元。** 截至上次收盘，该公司股价已累计下跌 10.7(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241209:nL4T3NA0N3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2489926008","title":"BUZZ-BioAge Labs 因取消肥胖症实验药物的中期试验而暴跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2489926008","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489926008?lang=zh_cn&edition=full","pubTime":"2024-12-07 07:04","pubTimestamp":1733526293,"startTime":"0","endTime":"0","summary":"12月6日 -  ** 药物开发商BioAge Labs BIOA.O股价在延时交易中暴跌67.6%至6.52美元 ** 由于在一些患者中发现某些肝酶水平过高，该公司终止了  的肥胖症实验药物中期试验 ** BioAge 公司的实验性药物 azelaprag 可模拟外泌尿素 apelin 的活性，apelin 是肌肉收缩时释放的一种肽。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nL3T3N71CX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2489264818","title":"BioAge 终止肥胖症药物中期试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2489264818","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489264818?lang=zh_cn&edition=full","pubTime":"2024-12-07 05:43","pubTimestamp":1733521413,"startTime":"0","endTime":"0","summary":"BioAge 终止肥胖症药物中期试验路透社12月6日 - BioAge Labs BIOA.O周五表示，该公司将终止对其实验性药物作为单一疗法和与礼来公司LLY.N的替唑帕肽联用治疗肥胖症的中期试验。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241206:nL3T3N71A5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999018857.SGD","LU1917777945.USD","LU0097036916.USD","LU0122379950.USD","LU0672654240.SGD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU1868836591.USD","LU1868836757.USD","LU1623119135.USD","SG9999014914.USD","LU0061475181.USD","LU0256863811.USD","LU2468319806.SGD","LU0820561818.USD","SGXZ51526630.SGD","IE0004445239.USD","IE00BJLML261.HKD","LLY","BK4599","LU0203201768.USD","SG9999013999.USD","LU1291159041.SGD","LU1127390331.HKD","LU0109391861.USD","LU2106854487.HKD","LU2491050154.USD","LU0256863902.USD","LU0096364046.USD","LU0471298777.SGD","SG9999015978.USD","SG9999015952.SGD","LU0823416689.USD","IE00B4R5TH58.HKD","LU2491049909.HKD","SGXZ31699556.SGD","LU2237443895.HKD","LU0882574139.USD","BK4534","LU0466842654.USD","IE00BJT1NW94.SGD","LU2491050071.SGD","LU2112291526.USD","BIOA","LU1814569148.SGD","LU0689472784.USD","LU1974910355.USD","SG9999015986.USD","LU1093756325.SGD","LU2211815571.USD"],"gpt_icon":0},{"id":"2477636551","title":"更新版 2-高盛支持的药物开发商 Septerna 在美国首次公开募股中目标估值 7.43 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477636551","media":"路透中文","labels":["shareholding","productRelease","event"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477636551?lang=zh_cn&edition=full","pubTime":"2024-10-24 20:08","pubTimestamp":1729771713,"startTime":"0","endTime":"0","summary":"更新版 2-高盛支持的药物开发商 Septerna 在美国首次公开募股中目标估值 7.43 亿美元第 3-5 段补充了生物技术行业的背景，第 6-7 段补充了 Septerna 的主要药物。路透10月24日 - 高盛支持的药物开发商赛普特纳公司周四表示，该公司将在美国进行规模更大的首次公开募股，寻求获得 7.431 亿美元的估值，这表明投资者对这一资本密集型行业的乐观情绪。高盛持有 Septerna 5.4% 的股份，该公司目前的目标是通过出售近 1530 万股每股 18 美元的股票筹集 2.75 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241024:nL4S3M01LN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,productRelease,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2237443465.HKD","BK4588","IE00BSNM7G36.USD","LU1791807156.HKD","LU2237438978.USD","LU2237443895.HKD","BIOA","BK4552","IE0002270589.USD","LU1668664300.SGD","BK4127","BK4550","LU2237443978.SGD","LU2237443382.USD","BK4585","IE0034235188.USD","IE00B19Z3B42.SGD","IE00B19Z3581.USD","LU2237443549.SGD","UPB","LU0106831901.USD","BCAX","MBX","BK4533","IE0004091025.USD","BK4007","IE0004086264.USD","BK4504","BK4139","LU2237443622.USD","IE00BFXG1179.USD"],"gpt_icon":0},{"id":"2477898085","title":"BUZZ--美国股票走势-豪迈航空航天公司、阿拉斯加航空公司、Arcus 生物科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477898085","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477898085?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:12","pubTimestamp":1729527131,"startTime":"0","endTime":"0","summary":"        *      个股异动的 Eikon 搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月21日 - 华尔街主要股指周一表现低迷，投资者在经历了前一周的大涨之后稍作喘息，等待各大公司的财报，这些财报可能会影响市场是维持纪录高位还是下跌。美东时间11:34，道琼斯工业平均指数  下跌0.9%，报42,881.14点。标普500指数  下跌0.63%，报5827.7点；纳斯达克综合指数  下跌0.50%，报18396.354点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLY","AMRX","RH","CI","UPS","BK4561","XOM","HWM","VVI","HTZ","CTRA","UDOW","ALK","SCWX","VFC","AUB","DXD","NEM","CVX",".IXIC","SYTA",".SPX","PSN","DOG","KIRK","HUM","DDM","SDOW","CRGY","RCUS","TARA","MGRX","BIOA","SAVE",".DJI","DJX","APA","LUMN","SEDG","INDB","DVN","JKS","PLL","HD"],"gpt_icon":1},{"id":"2477391868","title":"BUZZ--美国股票走势-BioAge Labs、Piedmont Lithium、联合包裹服务公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2477391868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477391868?lang=zh_cn&edition=full","pubTime":"2024-10-21 21:17","pubTimestamp":1729516656,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      10月21日 -    华尔街主要股指继前一周反弹后，周一准备下挫，在主要财报公布前，股指是从纪录高位回落还是维持上涨势头，可能会受到影响。美东时间9:02，道指电子盘  下跌0.12%，报43,466点。标普500指数小型股  下跌0.23%，报5892.25点；纳斯达克100指数小型股  下跌0.41%，报20398.5点。** Lumen Technologies Inc   ：盘前上涨18.1%BUZZ - 在宣布与Meta合作后上涨","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0612318971.USD","LU1066053197.SGD","LU1430597077.USD","VVI","LU0225284248.USD","LU0211331839.USD","BIOA","SYTA","LU0055631609.USD","MGRX","LUMN","NEM","IE00B7SZLL34.SGD","LU0320765646.SGD","ALLY","LU0788108826.HKD","UPS","LU1894683348.USD","BK4554","IE00B19Z3581.USD","SG9999001176.SGD","INDB","PLL","LU1894683264.USD","KIRK","LU0170899867.USD","LU2462611646.USD","BK4100","IE00B19Z3B42.SGD","SG9999013999.USD","LU0456855351.SGD","IE00BJJMRY28.SGD","BK4532","LU0149725797.USD","SEDG","LU1430594728.SGD","LU0070302665.USD","LU1023059063.AUD","IE00BJJMRX11.SGD","BK4551","LU1066051498.USD","HWM","LU0496367417.USD","SG9999002232.USD","SAVE","LU0300736492.USD"],"gpt_icon":1},{"id":"2477856129","title":"BUZZ-杰富瑞首推 BioAge Labs，\"买入 \"新型肥胖症药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2477856129","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477856129?lang=zh_cn&edition=full","pubTime":"2024-10-21 19:34","pubTimestamp":1729510484,"startTime":"0","endTime":"0","summary":"    10月21日 - ** 杰富瑞给予药物开发商BioAge Labs   \"买入 \"评级，目标价42美元。** 经纪公司称，BIOA的主要候选药物azelaprag具有新颖的机制，可作为治疗肥胖症的常用GLP-1药物的补充疗法，有助于在竞争日益激烈的市场中满足某些未得到满足的需求。** 杰富瑞预测该药物的最高收入将达到近 20 亿美元；称它针对的是 \"能量消耗\"，而其他药物针对的是能量摄入** 根据早期数据，券商预计该药物与单独使用 Zepbound/Wegovy 相比，可以帮助减轻更多体重，而且副作用更小。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE0009355771.USD","LU0640476718.USD","IE00B1BXHZ80.USD","LU0417517546.SGD","LU0114720955.EUR","LU0820561909.HKD","LU1035775433.USD","LU0006306889.USD","BK4585","IE00BJJMRZ35.SGD","GB00BDT5M118.USD","LU0289739699.SGD","LU0708995401.HKD","LU0238689110.USD","LU0354030438.USD","IE00B4R5TH58.HKD","LU0471298777.SGD","LU0882574055.USD","LU0203202063.USD","IE0004445239.USD","IE00BK4W5L77.USD","BK4581","JEF","LU0106261372.USD","LU0109391861.USD","LU0198837287.USD","LU0672654240.SGD","LU0689472784.USD","LU0823416689.USD","LU0094547139.USD","LU1093756168.USD","LU0943347566.SGD","LU0256863902.USD","BK4533","BIOA","LU0079474960.USD","LU0203201768.USD","IE00B2B36J28.USD","LU0354030511.USD","LU1064131342.USD","LU0097036916.USD","LU0471298694.HKD","IE00BJLML261.HKD","IE00BK4W5M84.HKD","BK4534","LU1061106388.HKD","LU0320765059.SGD","IE0002141913.USD"],"gpt_icon":1},{"id":"2474031923","title":"更新版 2-随着医疗保健行业上市热潮的兴起，上游生物和另外两家美国生物技术初创公司纷纷定价 IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2474031923","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474031923?lang=zh_cn&edition=full","pubTime":"2024-10-11 08:01","pubTimestamp":1728604880,"startTime":"0","endTime":"0","summary":"更新版 2-随着医疗保健行业上市热潮的兴起，上游生物和另外两家美国生物技术初创公司纷纷定价 IPO全文改写；第 3-10 段增加了细节和背景介绍。路透10月11日 - 周四，三家美国医疗保健初创企业首次公开募股定价，其中包括Upstream Bio UPB.O，该公司以约8.3亿美元的估值募集了2.55亿美元。Dealogic 的数据显示，9 月份是今年医疗保健行业 IPO 最繁忙的月份。CAMP4 的首次公开募股定价为每股 11 美元，远低于其 14 至 16 美元的目标区间。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241011:nL4T3LN006:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BIOA","BCAX","IPO","TPG","BK4135"],"gpt_icon":0},{"id":"2474225168","title":"更新版 2-TPG 支持的 CeriBell 在美国首次公开募股中寻求高达 5.78 亿美元的估值","url":"https://stock-news.laohu8.com/highlight/detail?id=2474225168","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474225168?lang=zh_cn&edition=full","pubTime":"2024-10-09 19:56","pubTimestamp":1728475011,"startTime":"0","endTime":"0","summary":"更新版 2-TPG 支持的 CeriBell 在美国首次公开募股中寻求高达 5.78 亿美元的估值CeriBell 发行 1,060 万股股票，此前为 670 万股首次公开募股价格区间从每股 14-16 美元提高到 16-17 美元部分现有投资者可购买价值高达 4000 万美元的股票在第 6、7 和 9-12 段增加了有关公司和首次公开募股的背景和详细信息。路透10月9日 - 由 TPG 支持的医疗设备制造商 CeriBell 周三表示，该公司将在美国进行规模更大的首次公开募股，目标估值高达 5.783 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241009:nL4T3LL12P:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0971096721.USD","LU0310800965.SGD","LU0417517546.SGD","LU1267930227.SGD","BCAX","IE00BLSP4452.SGD","BK4504","BIOA","LU1894683264.USD","LU2129689514.USD","BK4588","LU1201861165.SGD","LU0868494617.USD","LU1280957306.USD","LU0234572021.USD","LU1791807156.HKD","LU0306806265.USD","BK4135","IE00BZ1G4Q59.USD","BK4585","LU0070302665.USD","LU0648000940.SGD","LU1496350502.SGD","BK4559","IE00BFXG1179.USD","BK4139","IE00B19Z3581.USD","BK4207","IE00BLSP4239.USD","LU1668664300.SGD","LU1201861249.SGD","LU1162221912.USD","TPG","LU1074936037.SGD","IE00BKVL7J92.USD","BK4534","IE00B7SZLL34.SGD","LU1718418525.SGD","LU0640476718.USD","LU0256863811.USD","LU0053666078.USD","LU0321505439.SGD","LU0128525689.USD","LU1894683348.USD","LU0130103400.USD","BK4553","LU0321505868.SGD","LU0980610538.SGD","LU1496350171.SGD","BAC"],"gpt_icon":0},{"id":"2473285107","title":"肥胖药物生产商Rivus据悉考虑最快今年上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2473285107","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473285107?lang=zh_cn&edition=full","pubTime":"2024-10-07 23:30","pubTimestamp":1728315048,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BIOA","IPO","RA","161121"],"gpt_icon":0},{"id":"1186878787","title":"异动解读 | 生物科技新星BioAge Labs纳斯达克上市首日大涨6.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=1186878787","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1186878787?lang=zh_cn&edition=full","pubTime":"2024-09-27 21:36","pubTimestamp":1727444184,"startTime":"0","endTime":"0","summary":"9月27日,生物科技新星BioAge Labs Inc.在美国纳斯达克交易所成功挂牌上市,股价大涨6.36%,收于38.74美元,引发市场广泛关注。BioAge Labs主攻代谢疾病等人类衰老相关疾病的治疗领域,其主要候选药物azelaprag在多项临床试验中表现出良好的安全性和有效性。此外,生物科技公司是今年美国IPO市场的一大亮点,活跃的IPO市场为BioAge Labs上市大涨提供了良好环境。投资者偏好盈利前景明朗的公司,生物科技龙头BioAge Labs自然成为资金追捧对象。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BIOA"],"gpt_icon":0},{"id":"1163589295","title":"异动解读 | 生物科技新星BioAge Labs纳斯达克挂牌上市 股价大涨5.73%","url":"https://stock-news.laohu8.com/highlight/detail?id=1163589295","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1163589295?lang=zh_cn&edition=full","pubTime":"2024-09-27 20:56","pubTimestamp":1727441784,"startTime":"0","endTime":"0","summary":"生物科技新星BioAge Labs Inc.于2024年9月26日在美国纳斯达克交易所成功挂牌上市,首日股价大涨5.73%,反映了投资者对该公司未来发展前景的乐观预期。BioAge Labs主攻代谢疾病等人类衰老相关疾病的治疗领域,其主要候选药物azelaprag是一种口服小分子,已在多项临床试验中表现出良好的安全性和有效性。据招股书披露,BioAge Labs虽然暂无营收,但已累计获得超过3亿美元融资,投资者包括知名风险投资机构Andreessen Horowitz、Khosla Ventures等。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["BIOA"],"gpt_icon":0},{"id":"2470743424","title":"《图表新闻》美国IPO市场稳健回升后将延续复苏势头","url":"https://stock-news.laohu8.com/highlight/detail?id=2470743424","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470743424?lang=zh_cn&edition=full","pubTime":"2024-09-27 10:56","pubTimestamp":1727405798,"startTime":"0","endTime":"0","summary":"《图表新闻》美国IPO市场稳健回升后将延续复苏势头路透9月26日 - 受经济衰退担忧消退和股市飙升的推动，美国首次公开发行市场在经历了近两年的枯竭期后，于2024年强劲反弹。作为趋势指标的Renaissance IPO指数 .FTIPOUSA，今年迄今为止上涨了约14%。**生技公司大放异彩**Dealogic的数据显示，9月成为今年医疗保健行业IPO最繁忙的月份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20240927:nL6T3L9034:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","LINE","GRDN","RDDT","BKV","CON","IPO","BK4185","BK4224"],"gpt_icon":0},{"id":"2470971613","title":"生物科技公司BioAge Labs纳斯达克上市：市值6亿美元 路演PPT曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2470971613","media":"雷递网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470971613?lang=zh_cn&edition=full","pubTime":"2024-09-27 09:01","pubTimestamp":1727398919,"startTime":"0","endTime":"0","summary":"生物科技初创公司BioAge Labs（股票代码为：“BIOA”）昨日在美国纳斯达克上市，募资总额为1.98亿美元。BioAge Labs开盘价为22.5美元，较发行价上涨25%；收盘价为18.31美元，较发行价上涨1.72%；以收盘价计算，公司市值为6.16亿美元。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20240927/6386302451252659998745633.png","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20240927/6386302451252659998745633.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.leinews.com/n27839/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BIOA","PPT","03086","BK1147","QID","ARTL","BK4007",".IXIC","QLD","TQQQ","NQmain","PSQ","MNQmain","SQQQ"],"gpt_icon":1}],"profile":{"websiteUrl":"http://bioagelabs.com","stockEarnings":[{"period":"1week","weight":-0.1042},{"period":"1month","weight":-0.7627},{"period":"3month","weight":-0.7611},{"period":"ytd","weight":-0.7611}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"BioAge Labs, Inc.于2015年4月1日在特拉华州注册成立。他们是一家临床阶段的生物制药公司，通过针对人类衰老的生物学特性，开发治疗肥胖等代谢性疾病的候选产品。他们的技术平台和差异化的人类数据集使他们能够根据对驱动衰老的分子变化的见解来识别有前景的靶点。他们的主要关注点是代谢性疾病，这是全球最大的医疗保健挑战之一。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.008123},{"month":2,"riseRate":0.4,"avgChangeRate":-0.16094},{"month":3,"riseRate":0.2,"avgChangeRate":-0.091972},{"month":4,"riseRate":0.4,"avgChangeRate":-0.044244},{"month":5,"riseRate":0,"avgChangeRate":-0.19738},{"month":6,"riseRate":0.25,"avgChangeRate":0.003055},{"month":7,"riseRate":0.4,"avgChangeRate":-0.005696},{"month":8,"riseRate":0.4,"avgChangeRate":-0.229124},{"month":9,"riseRate":0.6,"avgChangeRate":0.004924},{"month":10,"riseRate":0.8,"avgChangeRate":0.181962},{"month":11,"riseRate":0.6,"avgChangeRate":0.056827},{"month":12,"riseRate":0.2,"avgChangeRate":-0.087267}],"exchange":"NASDAQ","name":"BioAge Labs Inc.","nameEN":"BioAge Labs Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供BioAge Labs Inc.(BIOA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"BioAge Labs Inc.,BIOA,BioAge Labs Inc.股票,BioAge Labs Inc.股票老虎,BioAge Labs Inc.股票老虎国际,BioAge Labs Inc.行情,BioAge Labs Inc.股票行情,BioAge Labs Inc.股价,BioAge Labs Inc.股市,BioAge Labs Inc.股票价格,BioAge Labs Inc.股票交易,BioAge Labs Inc.股票购买,BioAge Labs Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioAge Labs Inc.(BIOA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供BioAge Labs Inc.(BIOA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况